5,6-Dihydrobenzo[h]cinnolin-3-ylhydrazine
- Molecular formula
- C13H14N4
- CAS Number
- 14489-03-9
- IUPAC Name
- 5,6-dihydrobenzo[h]cinnolin-3-ylhydrazine
- Molecular Weight
- 222.27g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.1300g/cm3
- Synonyms
- WPR49QD923
Identification
5,6-Dihydrobenzo[h]cinnolin-3-ylhydrazine: Intriguing Insights
The compound 5,6-dihydrobenzohcinnolin-3-ylhydrazine is a fascinating subject of study for chemists and researchers alike. This hydrazine derivative belongs to a class of compounds that has garnered attention for its potential applications in medicinal chemistry. Here are some interesting aspects of this compound:
- Pharmaceutical Potential: Compounds like 5,6-dihydrobenzohcinnolin-3-ylhydrazine are known to exhibit biological activities that may be leveraged in the development of new pharmaceuticals, particularly in the fields of anti-cancer and anti-inflammatory drugs.
- Chemical Structure: The unique structural features of this compound, notably the fused ring system, contribute to its chemical properties and reactivity, paving the way for interesting synthetic approaches.
- Research Applications: This compound can serve as a crucial building block in the synthesis of more complex molecules, highlighting its importance in organic synthesis and medicinal chemistry.
- Studying Hydrazines: Hydrazine compounds are notable for their reactivity. Research into these materials often leads to discoveries in different fields, including materials science and agriculture.
Moreover, ongoing studies continue to explore the mechanisms through which such compounds exert their biological effects, emphasizing the need for continuous inquiry into the intricate relationships between structure and functionality. As researchers delve deeper, the potential for new discoveries based on the properties and applications of 5,6-dihydrobenzohcinnolin-3-ylhydrazine remains promising. With each advancement, this compound could play a pivotal role in addressing pressing health challenges.